The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Tolmar
Travel, Accommodations, Expenses - Tolmar
Low incidence of microsurges with biodegradable polymer-delivered, subcutaneously-administered leuprolide acetate in prostate cancer patients.
 
Eleni Efstathiou
Honoraria - Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer; Janssen-Cilag; Sanofi
Speakers' Bureau - Janssen-Cilag
Research Funding - Astellas Medivation; Janssen-Cilag; Sanofi
Other Relationship - Bayer; Innocrin Pharma; Janssen-Cilag; MSD; Sanofi; Takeda; Tolmar
 
John A. McLane
Employment - Tolmar
Travel, Accommodations, Expenses - Tolmar
 
Stuart Atkinson
Employment - Tolmar
Stock and Other Ownership Interests - Avadel Pharmaceuticals
 
Debbie Boldt-Houle
No Relationships to Disclose
 
A. Oliver Sartor
Stock and Other Ownership Interests - GlaxoSmithKline; Lilly; Noria Pharma Solutions
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Celgene; Constellation Pharmaceuticals; Dendreon; EMD Serono; Endocyte; Johnson & Johnson; Oncogenex; Pfizer; Progenics; Sanofi
Research Funding - Bayer (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Merck; Sanofi (Inst)
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Johnson & Johnson; Progenics; Sanofi